AtaiBeckley Insider Craig Kevin James Reports Ownership Change

TL;DR

**AtaiBeckley insider Craig Kevin James reported a change in ownership, watch for details.**

AI Summary

This Form 4 filing, dated March 24, 2026, indicates a change in beneficial ownership for Craig Kevin James, a reporting person for AtaiBeckley Inc. (Issuer CIK: 0002081043). While the filing itself doesn't detail the specific transaction, it signals that an insider's holdings have changed as of the period of report, March 20, 2026. This matters to investors because changes in insider ownership can sometimes signal management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price.

Why It Matters

Insider transactions can provide valuable signals about a company's health and future outlook, as those closest to the operations often have the most insight.

Risk Assessment

Risk Level: low — This filing is purely administrative, reporting a change in beneficial ownership, and does not inherently indicate a high risk.

Analyst Insight

An investor should monitor subsequent filings or company announcements for details regarding the nature of Craig Kevin James's ownership change (e.g., buy, sell, grant) to assess its potential implications for AtaiBeckley Inc.'s stock.

Key Players & Entities

• Craig Kevin James (person) — Reporting Person
• AtaiBeckley Inc. (company) — Issuer
• 0002081043 (company) — AtaiBeckley Inc.'s CIK
• 0002049601 (person) — Craig Kevin James's CIK
• 2026-03-24 (date) — Filing Date
• 2026-03-20 (date) — Period of Report

FAQ

Key Financial Figures

• $3.52 — ctions at per share prices ranging from $3.52 to $3.60. The Reporting Person undertak
• $3.60 — per share prices ranging from $3.52 to $3.60. The Reporting Person undertakes to pro

Filing Documents

• form4.html (4)
• form4.xml (4) — 11KB
• 0001140361-26-010932.txt ( ) — 12KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). X Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Craig Kevin James (Last) (First) (Middle) C/O ATAI LIFE SCIENCES US, INC. C/O INDUSTRIOUS NYC, 250 WEST 34TH ST. (Street) NEW YORK NEW YORK 10119 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol AtaiBeckley Inc. [ ATAI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Medical Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/20/2026 M (1) 76,224 A $ 1.18 84,661 D Common Stock 03/20/2026 M (1) 23,776 A $ 1.5 108,437 D Common Stock 03/20/2026 S (1) 100,000 D $ 3.55 (2) 8,437 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option $ 1.18 03/20/2026 M 76,224 (3) 03/14/2033 Common Stock 76,224 $ 0 38,136 D Stock Option $ 1.5 03/20/2026 M 23,776 (4) 03/03/2035 Common Stock 23,776 $ 0 734,139 D Explanation of Responses: 1. The option exercises and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025. 2. The stock option vested as to 25% of the underlying shares on March 14, 2024, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter. 3. The stock option vested as to 25% of the underlying shares on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter. 4. The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.52 to $3.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. /s/ Ryan Barrett, as attorney in fact 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * For

View Full Filing

View this 4 filing on SEC EDGAR